COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Ensuring global access to COVID-19 vaccines

Lancet.

Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK

doi: 10.1016/S0140-6736(20)30763-7.

Viral Infections, Non-HIV

Developing Covid-19 Vaccines at Pandemic Speed

N Engl J Med.

Lurie N, Saville M, Hatchett R, Halton J

doi: 10.1056/NEJMp2005630.

Viral Infections, Non-HIV

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients

Drug Saf.

Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S, ITA-COVID-19: RAAS inhibitor group.

doi: 10.1007/s40264-020-00994-5.

Viral Infections, Non-HIV

The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination

Swiss Med Wkly

Haaf P, Kuster GM, Mueller C, Berger CT, Monney P, Burger P, Stämpfli SF, Attenhofer Jost CH, Zellweger MJ, Osswald S, Donner BC, Koestner SC, Tanner FC

doi: 10.4414/smw.2021.w30087

Viral Infections, Non-HIV

Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis

Aging (Albany NY).

Xu L, Mao Y, Chen G

doi: 10.18632/aging.103383.

Viral Infections, Non-HIV

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

J Clin Virol.

Scohy A, Anantharajah A, Bodéus M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H

doi: 10.1016/j.jcv.2020.104455.

Viral Infections, Non-HIV

Vaccine designers take first shots at COVID-19

Science.

Cohen J

doi: 10.1126/science.368.6486.14.

Viral Infections, Non-HIV

Characteristics of Liver Tests in COVID-19 Patients

J Hepatol.

Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, Zhou G, Gou J, Qu J, Sun Y, Liu Y, He Q, Chen J, Liu L, Xu L

doi: 10.1016/j.jhep.2020.04.006.

Related content

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Ensuring global access to COVID-19 vaccines

Developing Covid-19 Vaccines at Pandemic Speed

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients

The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination

Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

Vaccine designers take first shots at COVID-19

Characteristics of Liver Tests in COVID-19 Patients